Clinical Trials Logo

Acne Vulgaris clinical trials

View clinical trials related to Acne Vulgaris.

Filter by:

NCT ID: NCT04106778 Completed - Acne Vulgaris Clinical Trials

DMT310-003 Topical in the Treatment of Acne Vulgaris

Start date: October 10, 2019
Phase: Phase 2
Study type: Interventional

The objective is to evaluate the tolerability, safety, and efficacy of DMT310 topical powder mixed with diluent in male and female patients with moderate to severe facial acne vulgaris.

NCT ID: NCT04104685 Completed - Acne Vulgaris Clinical Trials

A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam.

Start date: September 18, 2019
Phase: Phase 2
Study type: Interventional

A study comparing FCD105 to 3% minocycline foam, 0.3% adapalene foam and vehicle foam in patients ≥ 12 years old for the treatment of moderate-to-severe acne.

NCT ID: NCT04080869 Completed - Clinical trials for Facial Acne Vulgaris

Retinyl Palmitate-loaded Ethosomes in Acne Vulgaris

Start date: January 6, 2020
Phase: Phase 2
Study type: Interventional

Acne is a chronic inflammatory dermatosis of the pilosebaceous unit. Topical treatment is the first choice in mild and moderate cases of acne, especially topical retinoids. Although topical retinoids are very effective in the treatment of acne, local cutaneous irritation including burning, itching, erythema, peeling or dryness, is observed in a considerable number of patients, resulting in low patient compliance, compromising the efficacy of the therapy. Several approaches have been proposed to address these concerns, including the use of esters of retinoic acid (RA) and RA precursors, such as retinol and retinaldehyde, or novel drug delivery systems, which present the potential for controlled release, in turn reducing the aforementioned occurrences. Encapsulation of retinoids into vesicular carriers as liposomes and ethosomes and nanoparticulate carriers can significantly improve their effects for the treatment of acne compared with commercial formulations , providing better tolerability of irritating retinoid. The aim of work is to assess the efficacy and tolerability of the topical application of Retinyl Palmitate-loaded ethosome formulation in the treatment of acne vulgaris in comparison to conventional formulation of classic retinoids

NCT ID: NCT04060160 Recruiting - Acne Vulgaris Clinical Trials

Acne Detection Software (AcneDect)

AcneDect
Start date: October 29, 2020
Phase:
Study type: Observational

This study is to create a self-learning software that can detect acne lesions. Patients take a picture of their face every single day for 3 months with a secure mobile phone and fill out a pre-designed questionnaire. After 3 months, the mobile will be collected back and the pictures will be evaluated by 3 dermatologists. The software is able to learn from the dermatologists' evaluation and -using machine learning- a mechanism that should be able to automatically detect acne to some extent will be established.

NCT ID: NCT04059523 Completed - Acne Vulgaris Clinical Trials

MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3

Start date: June 27, 2019
Phase: Phase 1
Study type: Interventional

To assess the degree of systemic exposure of S6G5T-3 compared to the Reference Listed Drug (RLD) Retin-A® 0.1% Cream when applied topically once daily for 14 days, under maximal use conditions in adolescents ≥12 years of age and adults with acne vulgaris.

NCT ID: NCT04057768 Completed - Wrinkle Clinical Trials

Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles

Start date: August 19, 2019
Phase: N/A
Study type: Interventional

The objective of this clinical study is to evaluate the efficacy of fractional RF for the treatment and reduction of acne scarring or facial wrinkles.

NCT ID: NCT04056598 Completed - Acne Vulgaris Clinical Trials

Acne Vulgaris Related Microbiology and Serology

Start date: January 18, 2018
Phase:
Study type: Observational

This will be an investigation to determine the quality of the serological immune responses against Propionibacterium acnes (P. acnes) in acne patients compared to healthy individuals. In particular, the investigators will measure serum antibody titers against P. acnes surface antigens, and the efficiency of antibody-mediated phagocytic killing of P. acnes.

NCT ID: NCT04045119 Completed - Cosmetic Acne Clinical Trials

Effect of a Facial Cream Containing Cannabidiol and Hemp Oil on Skin Hydration and Acne-prone Skin

Dahlia
Start date: October 1, 2019
Phase: N/A
Study type: Interventional

This research seeks to evaluate the short (i.e., after single application) and long-term (i.e., after periodic application) hydrating effect of a topical preparation containing CBD and hemp oil on facial skin as well as the effect on erythema, appearance, instrumentally measured sebum production and quality of life.

NCT ID: NCT04044898 Completed - Acne Vulgaris Clinical Trials

Pharmacokinetics and Safety of ALA in Acne Vulgaris

Start date: January 12, 2021
Phase: Phase 1
Study type: Interventional

This study will evaluate the pharmacokinetics and safety of ALA in patients with moderate and severe acne vulgaris after single dose in different dosages.

NCT ID: NCT04028401 Recruiting - Clinical trials for Cutibacterium Acnes Infection

Optimization of Skin Preparation to Reduce Cutibacterium Acnes Colonization in Superficial and Deep Samples During Prosthetic Shoulder Surgery in Male Patients

OPRICA
Start date: June 19, 2020
Phase: Phase 3
Study type: Interventional

Infections on joint replacements remain one of the most serious complications of orthopaedic surgery. Despite improvements in skin preparation and antibiotic prophylaxis procedures, the risk of infection of joint prosthesis is still high, particularly for shoulder prostheses, especially in men. One of the bacteria most often involved in post-operative infections for shoulder prosthesis is Cutibacterium acnes (CA). This bacterium is one of the predominant bacteria in pilosebaceous units. Eradication of this micro-organism remains difficult despite the techniques used in the preoperative phase. The objective of this protocol is to evaluate the efficacy of applying a 5% benzoyl peroxide topical during the 5 days preceding the procedure in the surgical skin incision area, which is based on local acne treatment, on the reduction of the CA bacterial load in the dermis of the approach to shoulder arthroplasty in men.